Myasthenia Gravis Whole Blood
About: Whole blood from donors with confirmed myasthenia gravis. Useful for AChR autoantibody research and complement inhibitor therapy studies.
<h2>Myasthenia Gravis Whole Blood for Research</h2>
Myasthenia gravis is an autoimmune neuromuscular junction disorder most often driven by acetylcholine receptor (AChR) autoantibodies, causing fluctuating muscle weakness. Sanguine collects fresh whole blood from IRB-consented donors with a clinically confirmed myasthenia gravis diagnosis for neuroimmunology research.
<h3>Product Features</h3>
<ul><li>Fresh whole blood from clinically diagnosed myasthenia gravis donors</li><li>Custom anticoagulants and collection tubes available</li><li>Same-day collection and shipment</li><li>Research Use Only (RUO)</li></ul>
<h3>De-identified Donor Data</h3>
<ul><li>Physician-confirmed diagnosis, including autoantibody status where available</li><li>Demographics: age, sex assigned at birth, ethnicity</li><li>Relevant medical and treatment history</li></ul>
<h3>Applications</h3>
<ul><li>AChR autoantibody research</li><li>Neuromuscular junction biomarker studies</li><li>Gene expression and transcriptomic analysis</li><li>Complement inhibitor and biologic therapy response research</li></ul>
<h3>Also Available</h3>
Looking for a specific MG subtype? See our <a href=”https://sanguinebio.com/product/achr-myasthenia-gravis-whole-blood/”>AChR+</a>, <a href=”https://sanguinebio.com/product/generalized-myasthenia-gravis-whole-blood/”>Generalized</a>, <a href=”https://sanguinebio.com/product/ocular-myasthenia-gravis-whole-blood/”>Ocular</a>, and <a href=”https://sanguinebio.com/product/seronegative-myasthenia-gravis-whole-blood/”>Seronegative</a> Myasthenia Gravis Whole Blood products.
<h3>Compliance and Quality</h3>
<ul><li>IRB-approved protocols and electronic informed consent</li><li>HIPAA-compliant donor data handling</li></ul>
<h3>Ordering and Customization</h3>
Myasthenia gravis whole blood is available in standard and custom volumes. Email <a href=”mailto:learnmore@sanguinebio.com”>learnmore@sanguinebio.com</a> for international orders or documentation requirements.
Whole Blood
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – with the exception of GMP leukopaks, all our products are research use only (RUO).
1 Answer
Our complete catalog can be found here: https://sanguinebio.com/products/
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective colleciton services to tailored to fit your research. For more information and request a quote, please see: https://sanguinebio.com/prospective-biospecimen-collection-services/
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory which can be found here https://sanguinebio.com/products/?pro_inventory=inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: https://sanguinebio.com/quality-and-compliance/
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom Whole Blood cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.